Novartis Drug Under Review - fat lady starting to sing

[Rotten Swiss Cheeze]

here are the highlights

By JEANNE WHALEN
Europe's main drug regulator said it was starting a review of the Novartis AG hypertension pill aliskiren after a large clinical trial linked the drug to possible risks of nonfatal stroke and kidney problems

While it is reviewing the benefits and risks of the drug, the European Medicines Agency, or EMA, advised doctors to stop prescribing the drug

Aliskiren also failed to prove more effective than a placebo pill in the trial. Patients in the study were given either aliskiren or a placebo

DO ANY NVS FAT CHICKS KNOW OPERA ???? I HAVE A VIKING HAT YOU CAN WEAR

 

[Anonymous]

Not far behind .....the Canadians

press release

Dec. 22, 2011, 11:57 a.m. EST

Rasilez (Aliskiren): Health Canada Reviewing Safety of Blood-Pressure Drug

Health Canada will take appropriate regulatory action as necessary. Including strengthening and updating the drug labelling information with new safety information, Health professionals and the public will be informed of new safety recommendations

Novartis has indicated that it is no longer promoting Rasilez use

To report suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form ( http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php )